Skip to content

13F-HR filed by STATE OF WISCONSIN INVESTMENT BOARD

STATE OF WISCONSIN INVESTMENT BOARD filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 1,532 holding rows worth $35,870,859,000.

Accession
0001097241-19-000007
Filed
2019-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2019

A holdings report, 1,532 entries on the cover page, a total value of $35,870,859,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $35,870,853,000 with VALUE read as thousands by filing date, 13F file number 028-02519. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARDELYX INC039697107COM59,500$160,000thousands by filing date
NOVAVAX INC670002401COM NEW26,964$158,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK10,300$151,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM22,100$151,000thousands by filing date
LOGICBIO THERAPEUTICS INC54142F102COM11,400$148,000thousands by filing date
KALA BIO INC COM483119103Stock23,100$147,000thousands by filing date
SYNTHORX INC COM87167A103Stock10,600$143,000thousands by filing date
VERASTEM INC92337C104COM94,400$143,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM18,300$141,000thousands by filing date
DEUTSCHE BK AG NAMEN AKTD18190898Stock17,607$136,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock88,300$136,000thousands by filing date
iShares Gold Trust464285105ISHARES10,000$135,000thousands by filing date
Bowater Inc09066L105COMMON STOCKS122,600$135,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM11,500$132,000thousands by filing date
HI-CRUSH PARTNERS LP428337109COM UNIT LTD50,000$123,000thousands by filing date
GRITSTONE BIO INC39868T105COM10,000$111,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM21,600$107,000thousands by filing date
RESTORBIO INC76133L103COM10,500$107,000thousands by filing date
MOLECULAR TEMPLATES INC608550109COM12,600$105,000thousands by filing date
ADMA BIOLOGICS INC000899104COM26,600$103,000thousands by filing date
ADT INC DEL COM00090Q103Stock16,117$99,000thousands by filing date
SAVARA INC805111101COM39,700$94,000thousands by filing date
LSC COMMUNICATIONS INC50218P107COM25,000$92,000thousands by filing date
PPDAI GROUP INC69354V108SPONSORED ADR21,169$92,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM28,300$91,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock36,800$81,000thousands by filing date
POLARITYTE INC731094108COM14,000$80,000thousands by filing date
MENLO THERAPEUTICS INC586858102COM13,100$78,000thousands by filing date
TSAKOS ENERGY NAVIGATION LTDG9108L108SHS18,292$60,000thousands by filing date
NOVAGOLD RESOURCES INC66987E206COM NEW10,000$59,000thousands by filing date
RVL PHARMACEUTICALS PLCG6S41R101COM14,100$54,000thousands by filing date
TURQUOISE HILL RESOURCES LTD900435108COMMON STOCK-FO40,200$50,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001097241-19-000007this filing2019-08-14acceptance time not in the bulk data set